Literature DB >> 16412057

Reduced number of interleukin-12 secreting cells in patients with Lyme borreliosis previously exposed to Anaplasma phagocytophilum.

S Jarefors1, M Karlsson, P Forsberg, I Eliasson, J Ernerudh, C Ekerfelt.   

Abstract

Lyme borreliosis and human granulocytic ehrlichiosis are tick-borne diseases caused by Borrelia burgdorferi and Anaplasma phagocytophilum, respectively. Infection with A. phagocytophilum has been observed to induce immunosuppression and animal studies suggest that the bacteria might also have prolonged inhibitory effects on immune cells. The aim of this study was to investigate the cytokine secretion in patients exposed previously to A. phagocytophilum and currently infected with B. burgdorferi compared with patients infected with B. burgdorferi and seronegative for A. phagocytophilum. Eight patients with erythema migrans and antibodies against A. phagocytophilum, 15 patients with erythema migrans and negative A. phagocytophilum serology and 15 non-exposed healthy individuals were included in the study. Blood mononuclear cells were stimulated with Borrelia-antigen and the number of cytokine [interleukin (IL)-4, IL-5, IL-12, IL-13 and interferon (IFN)-gamma]-secreting cells was detected by enzyme-linked immunospot (ELISPOT). This study shows that patients with a previous exposure to A. phagocytophilum and a current infection with B. burgdorferi have a lower number of Borrelia-specific cells secreting IL-12 compared to Ap seronegative patients infected with B. burgdorferi (P < 0.001), indicating impairment in the ability to mount strong Th1-responses. We suggest that this mirrors a reduced Th1 response caused by A. phagocytophilum which could influence the outcome of the Borrelia infection and, speculatively, may also have implications in other conditions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16412057      PMCID: PMC1809588          DOI: 10.1111/j.1365-2249.2005.02993.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  33 in total

Review 1.  The expanding universe of T-cell subsets: Th1, Th2 and more.

Authors:  T R Mosmann; S Sad
Journal:  Immunol Today       Date:  1996-03

2.  T-helper-cell cytokines in the early evolution of murine Lyme arthritis.

Authors:  I Kang; S W Barthold; D H Persing; L K Bockenstedt
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

3.  Human disease in Europe caused by a granulocytic Ehrlichia species.

Authors:  M Petrovec; S Lotric Furlan; T A Zupanc; F Strle; P Brouqui; V Roux; J S Dumler
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

4.  Decreased interleukin-4 and increased gamma interferon production by peripheral blood mononuclear cells of patients with Lyme borreliosis.

Authors:  J Oksi; J Savolainen; J Pène; J Bòusquet; P Laippala; M K Viljanen
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

5.  T cell cytokine pattern in the joints of patients with Lyme arthritis and its regulation by cytokines and anticytokines.

Authors:  Z Yin; J Braun; L Neure; P Wu; U Eggens; A Krause; T Kamradt; J Sieper
Journal:  Arthritis Rheum       Date:  1997-01

6.  Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging?

Authors:  J S Bakken; J S Dumler; S M Chen; M R Eckman; L L Van Etta; D H Walker
Journal:  JAMA       Date:  1994-07-20       Impact factor: 56.272

7.  Prevalence of Borrelia burgdorferi sensu lato infection in Ixodes ricinus in Sweden.

Authors:  R Gustafson; T G Jaenson; A Gardulf; H Mejlon; B Svenungsson
Journal:  Scand J Infect Dis       Date:  1995

8.  The outer surface proteins of Lyme disease borrelia spirochetes stimulate T cells to secrete interferon-gamma (IFN-gamma): diagnostic and pathogenic implications.

Authors:  P Forsberg; J Ernerudh; C Ekerfelt; M Roberg; M Vrethem; S Bergström
Journal:  Clin Exp Immunol       Date:  1995-09       Impact factor: 4.330

9.  Dominant recognition of a Borrelia burgdorferi outer surface protein A peptide by T helper cells in patients with treatment-resistant Lyme arthritis.

Authors:  T Kamradt; B Lengl-Janssen; A F Strauss; G Bansal; A C Steere
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

10.  Clinical and laboratory characteristics of human granulocytic ehrlichiosis.

Authors:  J S Bakken; J Krueth; C Wilson-Nordskog; R L Tilden; K Asanovich; J S Dumler
Journal:  JAMA       Date:  1996-01-17       Impact factor: 56.272

View more
  4 in total

1.  Mercury exposure as a model for deviation of cytokine responses in experimental Lyme arthritis: HgCl2 treatment decreases T helper cell type 1-like responses and arthritis severity but delays eradication of Borrelia burgdorferi in C3H/HeN mice.

Authors:  C Ekerfelt; M Andersson; A Olausson; S Bergström; P Hultman
Journal:  Clin Exp Immunol       Date:  2007-08-02       Impact factor: 4.330

2.  Borrelia burgdorferi Is a Poor Inducer of Gamma Interferon: Amplification Induced by Interleukin-12.

Authors:  Frederik R van de Schoor; Hedwig D Vrijmoeth; Michelle A E Brouwer; Hadewych J M Ter Hofstede; Heidi L M Lemmers; Helga Dijkstra; Collins K Boahen; Marije Oosting; Bart-Jan Kullberg; Joppe W Hovius; Cees C van den Wijngaard; Frank L van de Veerdonk; Mihai G Netea; Leo A B Joosten
Journal:  Infect Immun       Date:  2022-02-07       Impact factor: 3.609

3.  ELISPOT assays and their diagnostic potential in Lyme disease and Lyme neuroborreliosis.

Authors:  N Ettischer-Schmid; R Preyer
Journal:  Clin Exp Immunol       Date:  2020-04-14       Impact factor: 4.330

Review 4.  Neuropsychiatric Lyme Borreliosis: An Overview with a Focus on a Specialty Psychiatrist's Clinical Practice.

Authors:  Robert C Bransfield
Journal:  Healthcare (Basel)       Date:  2018-08-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.